Shandong Huihai Pharmaceutical & Chemical Co., Ltd.
Shandong Huihai Pharmaceutical & Chemical Co., Ltd., commonly referred to as Huihai, is a prominent player in the pharmaceutical and chemical industry, headquartered in Shandong, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs), catering to both domestic and international markets. With a strong focus on research and innovation, Huihai offers a diverse range of products, including APIs for various therapeutic areas, which are distinguished by their purity and efficacy. The company has achieved notable recognition for its commitment to quality and compliance with international standards, positioning itself as a trusted supplier in the global pharmaceutical landscape. Through continuous investment in technology and sustainable practices, Shandong Huihai Pharmaceutical & Chemical Co., Ltd. remains dedicated to advancing healthcare solutions worldwide.
DitchCarbon Score
How does Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s score of 12 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s reported carbon emissions
In 2023, Shandong Huihai Pharmaceutical & Chemical Co., Ltd. reported total carbon emissions of approximately 762,000 kg CO2e from Scope 1 and 592,000 kg CO2e from Scope 2. This marks an increase from 2022, where emissions were about 734,000 kg CO2e for Scope 1 and 584,000 kg CO2e for Scope 2. The company has disclosed emissions data for both Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. Despite the increase in emissions over the past two years, Shandong Huihai has not set specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for enhanced focus on sustainability practices within the pharmaceutical and chemical industry. The company’s emissions per unit of revenue have shown some fluctuation, with a reported value of approximately 1.9e-06 kg CO2e per RMB in 2023, indicating a potential area for improvement in operational efficiency and carbon management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 629,000 | 000,000 | 000,000 |
| Scope 2 | 294,000 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong Huihai Pharmaceutical & Chemical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
